295 related articles for article (PubMed ID: 23364848)
1. ProEx C as an adjunct marker to improve cytological detection of urothelial carcinoma in urinary specimens.
Moatamed NA; Rao JY; Alexanian S; Cobarrubias M; Levin M; Lu D; Apple SK
Cancer Cytopathol; 2013 Jun; 121(6):320-8. PubMed ID: 23364848
[TBL] [Abstract][Full Text] [Related]
2. Utility of ProEx C in the histologic evaluation of the neoplastic and nonneoplastic urothelial lesions.
Moatamed NA; Vergara-Lluri ME; Lu D; Apple SK; Kerkoutian S; Rao JY
Hum Pathol; 2013 Nov; 44(11):2509-17. PubMed ID: 24029711
[TBL] [Abstract][Full Text] [Related]
3. Comparative evaluation of ProEx C and ImmunoCyt/uCyt assays in atypical urine cytology.
Vergara-Lluri ME; Hu E; Rao JY; Levin M; Apple SK; Moatamed NA
Arch Pathol Lab Med; 2014 Sep; 138(9):1215-22. PubMed ID: 25171704
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of p16INK4a, minichromosome maintenance protein 2, DNA topoisomerase IIalpha, ProEX C, and p16INK4a/ProEX C in cervical squamous intraepithelial lesions.
Shi J; Liu H; Wilkerson M; Huang Y; Meschter S; Dupree W; Schuerch C; Lin F
Hum Pathol; 2007 Sep; 38(9):1335-44. PubMed ID: 17512033
[TBL] [Abstract][Full Text] [Related]
5. Comparison of ProEx C with p16INK4a and Ki-67 immunohistochemical staining of cell blocks prepared from residual liquid-based cervicovaginal material: a pilot study.
Halloush RA; Akpolat I; Jim Zhai Q; Schwartz MR; Mody DR
Cancer; 2008 Dec; 114(6):474-80. PubMed ID: 19016301
[TBL] [Abstract][Full Text] [Related]
6. Expression of ProEx C in primary and metastatic urothelial carcinoma.
Liu L; Cohen C; Siddiqui MT
Diagn Cytopathol; 2015 Mar; 43(3):181-7. PubMed ID: 24975746
[TBL] [Abstract][Full Text] [Related]
7. ProEx C stain analysis in recurrent respiratory papillomatosis.
Bhandarkar ND; Sims HS; David O
Ann Otol Rhinol Laryngol; 2010 Feb; 119(2):99-104. PubMed ID: 20336920
[TBL] [Abstract][Full Text] [Related]
8. ProEx C as Diagnostic Marker for Detection of Urothelial Carcinoma in Urinary Samples: A Review.
Botti G; Malzone MG; La Mantia E; Montanari M; Vanacore D; Rossetti S; Quagliariello V; Cavaliere C; Di Franco R; Castaldo L; Ametrano G; Cappuccio F; Romano FJ; Piscitelli R; Pepe MF; D'Aniello C; Facchini G
Int J Med Sci; 2017; 14(6):554-559. PubMed ID: 28638271
[TBL] [Abstract][Full Text] [Related]
9. BD ProEx C: a sensitive and specific marker of HPV-associated squamous lesions of the cervix.
Badr RE; Walts AE; Chung F; Bose S
Am J Surg Pathol; 2008 Jun; 32(6):899-906. PubMed ID: 18425044
[TBL] [Abstract][Full Text] [Related]
10. Comparison of p16INK4a and ProEx C immunostaining on cervical ThinPrep cytology and biopsy specimens.
Oberg TN; Kipp BR; Vrana JA; Bartholet MK; Fales CJ; Garcia R; McDonald AN; Rosas BL; Henry MR; Clayton AC
Diagn Cytopathol; 2010 Aug; 38(8):564-72. PubMed ID: 19937941
[TBL] [Abstract][Full Text] [Related]
11. [Diagnostic importance of ProEx C in gynecologic cytopathology].
Tambouret RH
Ann Pathol; 2008 Nov; 28 Spec No 1(1):S92-3. PubMed ID: 18984316
[No Abstract] [Full Text] [Related]
12. Atypical urothelial tissue fragments in noninstrumented voided urine specimens are associated with low but significantly higher rates of urothelial neoplasia than benign-appearing urothelial tissue fragments.
Onur I; Rosenthal DL; VandenBussche CJ
Cancer Cytopathol; 2015 Mar; 123(3):186-92. PubMed ID: 25586692
[TBL] [Abstract][Full Text] [Related]
13. Detecting high-grade cervical disease on ASC-H cytology: role of BD ProEx C and Digene Hybrid Capture II HPV DNA testing.
Siddiqui MT; Cohen C; Nassar A
Am J Clin Pathol; 2008 Nov; 130(5):765-70. PubMed ID: 18854269
[TBL] [Abstract][Full Text] [Related]
14. Quantitative detection of molecular markers ProEx C (minichromosome maintenance protein 2 and topoisomerase IIa) and MIB-1 in liquid-based cervical squamous cell cytology.
Beccati MD; Buriani C; Pedriali M; Rossi S; Nenci I
Cancer; 2008 Jun; 114(3):196-203. PubMed ID: 18442059
[TBL] [Abstract][Full Text] [Related]
15. Immunocytochemical analysis of prostate stem cell antigen as adjunct marker for detection of urothelial transitional cell carcinoma in voided urine specimens.
Cheng L; Reiter RE; Jin Y; Sharon H; Wieder J; Lane TF; Rao J
J Urol; 2003 Jun; 169(6):2094-100. PubMed ID: 12771726
[TBL] [Abstract][Full Text] [Related]
16. Benign-appearing urothelial tissue fragments in noninstrumented voided urine specimens are associated with low rates of urothelial neoplasia.
Onur I; Rosenthal DL; VandenBussche CJ
Cancer Cytopathol; 2015 Mar; 123(3):180-5. PubMed ID: 25586552
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of atypical urine cytology progression to malignancy.
Muus Ubago J; Mehta V; Wojcik EM; Barkan GA
Cancer Cytopathol; 2013 Jul; 121(7):387-91. PubMed ID: 23536358
[TBL] [Abstract][Full Text] [Related]
18. Usefulness of p16ink4a, ProEX C, and Ki-67 for the diagnosis of glandular dysplasia and adenocarcinoma of the cervix uteri.
Negri G; Bellisano G; Carico E; Faa G; Kasal A; Antoniazzi S; Egarter-Vigl E; Piccin A; Dalla Palma P; Vittadello F
Int J Gynecol Pathol; 2011 Jul; 30(4):407-13. PubMed ID: 21623205
[TBL] [Abstract][Full Text] [Related]
19. Detection of cervical high-grade squamous intraepithelial lesions from cytologic samples using a novel immunocytochemical assay (ProEx C).
Kelly D; Kincaid E; Fansler Z; Rosenthal DL; Clark DP
Cancer; 2006 Dec; 108(6):494-500. PubMed ID: 17063495
[TBL] [Abstract][Full Text] [Related]
20. Biomarker (ProEx C, p16(INK4A), and MiB-1) distinction of high-grade squamous intraepithelial lesion from its mimics.
Pinto AP; Schlecht NF; Woo TY; Crum CP; Cibas ES
Mod Pathol; 2008 Sep; 21(9):1067-74. PubMed ID: 18552822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
